XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.1
SHARE-BASED COMPENSATION (Tables)
 6 Months Ended
Apr. 30, 2023
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses The table below presents information on our share-based compensation expenses for the three and six-month periods ended April 30, 2023, and May 1, 2022.


    Three Months Ended     Six Months Ended  
   
April 30,
2023
    
May 1,
2022
    
April 30,
2023
   
May 1,
2022
 
Expense reported in:
                        
     Cost of goods sold
  
$
288
    
$
182
     $ 570     $ 324  
     Selling, general, and administrative
    
1,531
      
1,243
       2,908       2,424  
     Research and development
    
190
      
159
       352       293  
Total expense incurred
  
$
2,009
    
$
1,584
     $ 3,830     $ 3,041  
                                 
Expense by award type:
                                
     Restricted stock awards
  
$
1,974
    
$
1,316
     $ 3,738     $ 2,683  
     Stock options
    
-
      
221
       1       259  
     Employee stock purchase plan
    
35
      
47
       91       99  
Total expense incurred
 
$
2,009
    
$
1,584
     $ 3,830     $ 3,041  
                                 
Income tax benefits of share-based compensation
  
$
207
    
$
104
     $ 361     $ 188  
Share-based compensation cost capitalized
  
$
-
    
$
-
     $ -     $ -  
Restricted Stock Awards Activity The table below presents information on our restricted stock awards for the three and six-month periods ended April 30, 2023, and May 1, 2022.


   
Three Months Ended
     Six Months Ended  
   
April 30,
2023
    
May 1,
2022
    
April 30,
2023
    
May 1,
2022
 
Number of shares granted in period
    
-
      
-
       786,500       535,400  
Weighted-average grant-date fair value of awards (in dollars per share)
  
$
-
    
$
-
     $ 16.77     $ 19.28  
Compensation cost not yet recognized
  
$
16,419
    
$
10,779
     $ 16,419     $ 10,779  
Weighted-average amortization period for cost not yet recognized (in years)
    
3.0
      
2.8
       3.0       2.8  
Shares outstanding at balance sheet date
    
1,328,572
      
891,429
       1,328,572       891,429  
Stock Options Activity The table below presents information on our stock options for the three and six-month periods ended April 30, 2023, and May 1, 2022.


   
Three Months Ended
     Six Months Ended
  
   
April 30,
2023
    
May 1,
2022
    
April 30,
2023
    
May 1,
2022
  
Number of options granted in period
    
-
      
-
       -       -  
Cash received from options exercised
  
$
20
    
$
438
     $ 583     $ 4,149  
Compensation cost not yet recognized
  
$
-
    
$
52
     $ -     $ 52  
Weighted-average amortization period for cost not yet recognized (in years)
    
-
      
0.7
      
-
       0.7  
Information on Outstanding and Exercisable Option

Information on outstanding and exercisable option awards as of April 30, 2023, is presented below.

Options
  
Shares
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (in years)
    
Aggregate
Intrinsic
Value
  
Outstanding and exercisable at April 30, 2023
    
526,926
    
$
10.11
      
2.99
    
$
2,293